359 related articles for article (PubMed ID: 26659912)
1. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
Inokuchi J; Naito S; Fujimoto H; Hara T; Sakura M; Nishiyama H; Miyazaki J; Kikuchi E; Hinotsu S; Koie T; Ohyama C;
Int J Urol; 2016 Mar; 23(3):224-30. PubMed ID: 26659912
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study.
Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M
Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.
Seisen T; Jindal T; Karabon P; Sood A; Bellmunt J; Rouprêt M; Leow JJ; Vetterlein MW; Sun M; Alanee S; Choueiri TK; Trinh QD; Menon M; Abdollah F
Eur Urol; 2017 May; 71(5):714-718. PubMed ID: 27912971
[TBL] [Abstract][Full Text] [Related]
4. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
Aboumohamed AA; Krane LS; Hemal AK
J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi-institutional national database of the Japanese Urological Association.
Hara T; Fujimoto H; Sakura M; Inokuchi J; Nishiyama H; Miyazaki J; Ohyama C; Koie T; Kikuchi E; Hinotsu S;
Int J Urol; 2015 Nov; 22(11):1013-20. PubMed ID: 26242807
[TBL] [Abstract][Full Text] [Related]
6. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A.
Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S
World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102
[TBL] [Abstract][Full Text] [Related]
7. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
[TBL] [Abstract][Full Text] [Related]
8. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes.
Chakiryan N; Martinez A; Gao L; Liu JJ; Amling C; Garzotto M; Kopp RP
J Urol; 2019 Jul; 202(1):76-82. PubMed ID: 30925108
[TBL] [Abstract][Full Text] [Related]
10. Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival.
Das AK; Carson CC; Bolick D; Paulson DF
Cancer; 1990 Nov; 66(9):1919-23. PubMed ID: 2224787
[TBL] [Abstract][Full Text] [Related]
11. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
[TBL] [Abstract][Full Text] [Related]
12. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
[TBL] [Abstract][Full Text] [Related]
13. Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy.
Hurel S; Rouprêt M; Ouzzane A; Rozet F; Xylinas E; Zerbib M; Berod AA; Ruffion A; Adam E; Cussenot O; Houlgatte A; Phé V; Nouhaud FX; Bensadoun H; Delage F; Guillotreau J; Guy L; Karsenty G; De La Taille A; Colin P;
BJU Int; 2013 Jun; 111(8):1199-207. PubMed ID: 23650914
[TBL] [Abstract][Full Text] [Related]
14. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
15. Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.
Makise N; Morikawa T; Kawai T; Nakagawa T; Kume H; Homma Y; Fukayama M
Int J Clin Exp Pathol; 2015; 8(6):7203-9. PubMed ID: 26261615
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
[TBL] [Abstract][Full Text] [Related]
17. Editorial Comment from Dr Miyata and Dr Sakai to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
Miyata Y; Sakai H
Int J Urol; 2016 Mar; 23(3):230-1. PubMed ID: 26840209
[No Abstract] [Full Text] [Related]
18. Editorial Comment from Dr Sakano and Dr Matsuyama to Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
Sakano S; Matsuyama H
Int J Urol; 2016 Mar; 23(3):231-2. PubMed ID: 26822627
[No Abstract] [Full Text] [Related]
19. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of lymphovascular invasion in upper urinary tract urothelial cancer.
Akao J; Matsuyama H; Yamamoto Y; Hara T; Kawai Y; Sakano S; Ohmi C; Gondo T; Naito K
BJU Int; 2008 Aug; 102(5):572-5. PubMed ID: 18485032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
